INDGN
Indegene Limited
Healthcare Research, Analytics & Technology
Share price
₹596
Market cap
₹14,370 Cr
1Y return
▲ 5%
A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.
Investors holding Indegene Limited
Recent moves 14
Moves14
Quant Mutual FundNew position
Quant Mutual Fund bought 9,523,810 shares of Indegene Limited for ₹500.00 Cr at ₹525.00 apiece in a block deal.
Read more
Government Pension Fund Global (Norway)Increased
Government Pension Fund Global (Norway) bought 4,80,000 shares of Indegene Limited for ₹25.20 Cr at ₹525.00 apiece in a block deal.
Read more
Morgan StanleyNew position
Morgan Stanley bought 665,048 shares of Indegene Limited in a block deal on August 6, 2026, for ₹34.92 crore at ₹525.00 apiece.
Read more
ICICI Prudential Mutual FundNew position
ICICI Prudential Mutual Fund bought 67,67,239 shares of Indegene Limited for ₹355.28 Cr at ₹525.00 apiece in a block deal.
Read more
Goldman SachsNew position
Goldman Sachs bought 477,000 shares of Indegene Limited for ₹25.04 Cr at ₹525.00 apiece in a block deal.
Read more
CitigroupNew position
Citigroup bought 477,000 shares of Indegene Limited in a block deal for ₹25.04 Cr at ₹525.00 apiece.
Read more
Buoyant CapitalNew position
Buoyant Capital bought 9,60,000 shares of Indegene Limited for ₹50.40 Cr at ₹525.00 apiece in a block deal.
Read more
Bajaj Allianz Life InsuranceNew position
Bajaj Allianz Life Insurance bought 952,381 shares of Indegene Limited for ₹50.00 Cr at ₹525.00 apiece in a block deal on August 6, 2026.
Read more
American Funds (Capital Group)Decreased
American Funds (Capital Group) trimmed its stake in Indegene Limited from 1.75% to 1.42%, selling 813,672 shares. The value of the sold shares was ₹44.38 crore, at a price of ₹545.25 per share.
Read more
FidelityDecreased
Fidelity trimmed its stake in Indegene Limited from 1.58% to 1.50%, selling 207,134 shares worth ₹11.29 crore at an average price of ₹545.25 per share.
Read more